Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MESOBLAST-LIMITED-6499027/news/Key-Day-100-Survival-Outcomes-of-Phase-3-Trial-for-Acute-Graft-Versus-Host-Disease-Presented-at-2018-26802411/?utm_source=whatsapp&utm_medium=social&utm_campaign=share